The Magellan System is a fully automated, dual spin, self-balancing, microprocessor driven system with intelligent detection capabilities utilizing optic sensors in addition to centrifugal force and cell density for cell separation. This system was designed to be gentle on the cells and flow cytometry testing showed 97% of platelets are not activated during processing. In addition, the Magellan does not depend upon user accuracy for product quality and it is not a hematocrit dependent system. Together, these benefits allow for a consistent and reproducible product. 

The Magellan System is a closed system with physical barriers. Once the starting volume is connected to the disposable, the user only has to enter the desired final volume and press the start button. The system does the rest. At the end of the cycle, the user only has to disconnect the 10 mL syringe containing PRP or MAR0 product and transfer to the sterile field. This ease of use increases safety, as well as, product consistency

The Magellan System:

Allows you to choose from 3 to 10 mL of final product volume from between 30 and 60 mL of starting volume per spin. It is FDA approved for up to three separate spins per disposable per patient. So, there are many options for final volume and concentration levels giving the ability to customize the final product per patient and procedure. In addition, the final volume is drawn off automatically while the system is still spinning at 1,000 RPMs which allows the total final volume to come from the most concentrated portion of the buffy coat and plasma. This helps to maximize cellular content. See below for our Platelet Concentration Chart showing many of the volume and concentration possibilities.

Multiple Beneficial Applications for One Kit Cost: 1) Our MARO products can be applied with graft material to an orthopedic site. 2) PRP & PPP can be processed from whole blood during the same procedure for no additional cost.  We are seeing PRP being utilized for soft tissue healing and infection prevention and PPP for hemostasis upon closure. In the office setting, this gives you the option to produce the volume and platelet concentration desired to treat multiple sites in the same visit for no additional cost. For example, cBMA injections for OA of both knees and PRP for Tennis Elbow.

See more at: http://www.arteriocyte.com

MAGELLAN Autologous Platelet Separator